StockGuru News: HealthSonix Commences New Clinical Trials to Expand Medical Claims for AquaSonix Therapy
HealthSonix Commences New Clinical Trials to Expand Medical Claims for AquaSonix Therapy HealthSonix Inc. (OTC: HSXI) IRVINE, CA–(MARKET WIRE)–Nov 9, 2006 — HealthSonix, Inc. (Other OTC:HSXI.PK - News) (Frankfurt:H7S.F - News) today announced it has commenced a new AquaSonix Therapy clinical trial with patients suffering with pain from osteoarthritis of the knee. The study group has been randomly divided into two groups: one group receives the actual sound pressure wave treatments, while the second control or placebo group, does not. “This clinical study is a Prospective, Randomized, Double-Blind, Single-Centre, Eight Week Trial to Baseline,” stated Dr. David Venturi, Medical Director…